<VariationArchive VariationID="419011" VariationName="NM_006516.4(SLC2A1):c.505_507del (p.Leu169del)" VariationType="Deletion" Accession="VCV000419011" Version="10" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-02-20" DateCreated="2017-04-27" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="405177" VariationID="419011">
      <GeneList>
        <Gene Symbol="SLC2A1" FullName="solute carrier family 2 member 1" GeneID="6513" HGNC_ID="HGNC:11005" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p34.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="42925353" stop="42958868" display_start="42925353" display_stop="42958868" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="43391045" stop="43424846" display_start="43391045" display_stop="43424846" Strand="-" />
          </Location>
          <OMIM>138140</OMIM>
          <Haploinsufficiency last_evaluated="2016-03-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC2A1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2016-03-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC2A1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_006516.4(SLC2A1):c.505_507del (p.Leu169del)</Name>
      <CanonicalSPDI>NC_000001.11:42930634:GAGGA:GA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1p34.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="43396306" stop="43396308" display_start="43396306" display_stop="43396308" variantLength="3" positionVCF="43396305" referenceAlleleVCF="TGAG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="42930635" stop="42930637" display_start="42930635" display_stop="42930637" variantLength="3" positionVCF="42930634" referenceAlleleVCF="TGAG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>L169del</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.43396308_43396310del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.43396308_43396310del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.42930637_42930639del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.42930637_42930639del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008232.1" sequenceAccession="NG_008232" sequenceVersion="1" change="g.33540_33542del">
            <Expression>NG_008232.1:g.33540_33542del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006516.4" sequenceAccession="NM_006516" sequenceVersion="4" change="c.505_507del" MANESelect="true">
            <Expression>NM_006516.4:c.505_507del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006507.2" sequenceAccession="NP_006507" sequenceVersion="2" change="p.Leu169del">
            <Expression>NP_006507.2:p.Leu169del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1132" sequenceAccession="LRG_1132">
            <Expression>LRG_1132:g.33540_33542del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1132t1" sequenceAccession="LRG_1132t1">
            <Expression>LRG_1132t1:c.505_507del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA16617148" DB="ClinGen" />
        <XRef Type="rs" ID="80359832" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006516.4(SLC2A1):c.505_507del (p.Leu169del) AND not provided" Accession="RCV000478031" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-01-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_006516.4(SLC2A1):c.505_507del (p.Leu169del) AND Childhood onset GLUT1 deficiency syndrome 2" Accession="RCV002470868" Version="1">
        <ClassifiedConditionList TraitSetID="5232">
          <ClassifiedCondition DB="MedGen" ID="C1842534">Childhood onset GLUT1 deficiency syndrome 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-02-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_006516.4(SLC2A1):c.505_507del (p.Leu169del) AND GLUT1 deficiency syndrome 1, autosomal recessive" Accession="RCV001851153" Version="5">
        <ClassifiedConditionList TraitSetID="5231">
          <ClassifiedCondition DB="MedGen" ID="C3149117">GLUT1 deficiency syndrome 1, autosomal recessive</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-07-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_006516.4(SLC2A1):c.505_507del (p.Leu169del) AND Encephalopathy due to GLUT1 deficiency" Accession="RCV003446077" Version="2">
        <ClassifiedConditionList TraitSetID="5230">
          <ClassifiedCondition DB="MedGen" ID="C4551966">Encephalopathy due to GLUT1 deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-12-18" SubmissionCount="2">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-18" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2017-04-27" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15622525</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18451999</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20129935</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26193382</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30271476</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31302675</ID>
        </Citation>
        <DescriptionHistory Dated="2024-02-08">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="5230" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1929" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GLUT1 deficiency syndrome 1, infantile onset, severe</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GLUT1 deficiency syndrome 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glucose transport defect, blood-brain barrier</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glucose transporter protein syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Encephalopathy due to GLUT1 deficiency</ElementValue>
                <XRef ID="MONDO:0011724" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">De Vivo disease</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">GLUT1DS1</ElementValue>
                <XRef Type="MIM" ID="606777" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypic spectrum of glucose transporter type 1 deficiency syndrome (Glut1 DS) is now known to be a continuum that includes the classic phenotype as well as paroxysmal exercise-induced dyskinesia and epilepsy (previously known as dystonia 18 [DYT18]) and paroxysmal choreoathetosis with spasticity (previously known as dystonia 9 [DYT9]), atypical childhood absence epilepsy, myoclonic astatic epilepsy, and paroxysmal non-epileptic findings including intermittent ataxia, choreoathetosis, dystonia, and alternating hemiplegia. The classic phenotype is characterized by infantile-onset seizures, delayed neurologic development, acquired microcephaly, and complex movement disorders. Seizures in classic early-onset Glut1 DS begin before age six months. Several seizure types occur: generalized tonic or clonic, focal, myoclonic, atypical absence, atonic, and unclassified. In some infants, apneic episodes and abnormal episodic eye-head movements similar to opsoclonus may precede the onset of seizures. The frequency, severity, and type of seizures vary among affected individuals and are not related to disease severity. Cognitive impairment, ranging from learning disabilities to severe intellectual disability, is typical. The complex movement disorder, characterized by ataxia, dystonia, and chorea, may occur in any combination and may be continuous, paroxysmal, or continual with fluctuations in severity influenced by environmental factors such as fasting or with infectious stress. Symptoms often improve substantially when a ketogenic diet is started.</Attribute>
                <XRef ID="NBK1430" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9265" />
                <XRef ID="9265" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301603</ID>
                <ID Source="BookShelf">NBK1430</ID>
              </Citation>
              <XRef ID="71277" DB="Orphanet" />
              <XRef ID="C4551966" DB="MedGen" />
              <XRef ID="MONDO:0011724" DB="MONDO" />
              <XRef Type="MIM" ID="606777" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5231" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9222" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">GLUT1 deficiency syndrome 1, autosomal recessive</ElementValue>
              </Name>
              <XRef ID="C3149117" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5232" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1930" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Dystonia 18</ElementValue>
                <XRef ID="Dystonia+18/2414" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Paroxysmal exertion-induced dyskinesia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Paroxysmal exercise-induced dystonia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PAROXYSMAL EXERCISE-INDUCED DYSKINESIA WITH OR WITHOUT EPILEPSY AND/OR HEMOLYTIC ANEMIA</ElementValue>
                <XRef Type="MIM" ID="612126" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PAROXYSMAL EXERTION-INDUCED DYSTONIA WITH OR WITHOUT EPILEPSY AND/OR HEMOLYTIC ANEMIA</ElementValue>
                <XRef Type="MIM" ID="612126" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PED WITH OR WITHOUT EPILEPSY AND/OR HEMOLYTIC ANEMIA</ElementValue>
                <XRef Type="MIM" ID="612126" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PxMD-SLC2A1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GLUT1 deficiency syndrome 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Childhood onset GLUT1 deficiency syndrome 2</ElementValue>
                <XRef ID="MONDO:0012805" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DYT18</ElementValue>
                <XRef Type="MIM" ID="612126" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PED</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">GLUT1DS2</ElementValue>
                <XRef Type="MIM" ID="612126" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypic spectrum of glucose transporter type 1 deficiency syndrome (Glut1 DS) is now known to be a continuum that includes the classic phenotype as well as paroxysmal exercise-induced dyskinesia and epilepsy (previously known as dystonia 18 [DYT18]) and paroxysmal choreoathetosis with spasticity (previously known as dystonia 9 [DYT9]), atypical childhood absence epilepsy, myoclonic astatic epilepsy, and paroxysmal non-epileptic findings including intermittent ataxia, choreoathetosis, dystonia, and alternating hemiplegia. The classic phenotype is characterized by infantile-onset seizures, delayed neurologic development, acquired microcephaly, and complex movement disorders. Seizures in classic early-onset Glut1 DS begin before age six months. Several seizure types occur: generalized tonic or clonic, focal, myoclonic, atypical absence, atonic, and unclassified. In some infants, apneic episodes and abnormal episodic eye-head movements similar to opsoclonus may precede the onset of seizures. The frequency, severity, and type of seizures vary among affected individuals and are not related to disease severity. Cognitive impairment, ranging from learning disabilities to severe intellectual disability, is typical. The complex movement disorder, characterized by ataxia, dystonia, and chorea, may occur in any combination and may be continuous, paroxysmal, or continual with fluctuations in severity influenced by environmental factors such as fasting or with infectious stress. Symptoms often improve substantially when a ketogenic diet is started.</Attribute>
                <XRef ID="NBK1430" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10541" />
                <XRef ID="10541" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301603</ID>
                <ID Source="BookShelf">NBK1430</ID>
              </Citation>
              <XRef ID="98811" DB="Orphanet" />
              <XRef ID="C1842534" DB="MedGen" />
              <XRef ID="MONDO:0012805" DB="MONDO" />
              <XRef Type="MIM" ID="612126" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1101627" SubmissionDate="2019-01-29" DateLastUpdated="2017-04-27" DateCreated="2017-04-27">
        <ClinVarSubmissionID localKey="GDX:409294|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000566520" DateUpdated="2017-04-27" DateCreated="2017-04-27" Type="SCV" Version="4" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-01-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.505_507delCTC pathogenic variant in the SLC2A1 gene has been reported multiple times previously (as 686delCTC or 684-686delCTC due to alternative nomenclature) in association with glucose transporter type 1 deficiency syndrome (Glut1-DS) (Pascual et al., 2002; Wang et al., 2005;). The c.505_507delCTC variant causes an in-frame deletion of a Leucine residue at codon 169, denoted p.Leu169del. The c.505_507delCTC variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC2A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006516.2:c.505_507delCTC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5412642" SubmissionDate="2022-12-21" DateLastUpdated="2022-12-24" DateCreated="2022-12-24">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_006516_3_SLC2A1_c_505_507delCTC" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002767188" DateUpdated="2022-12-24" DateCreated="2022-12-24" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18451999</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20129935</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26193382</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30271476</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with dystonia 9 (MIM#601042), infantile-onset GLUT1 deficiency syndrome 1 (MIM#606777), childhood-onset GLUT1 deficiency syndrome 2 (GDS) (MIM#612126) and stomatin-deficient cryohydrocytosis with neurologic defects, (MIM#608885). (I) 0107 - This gene is associated with autosomal dominant disease. Autosomal recessive disease has been rarely reported (OMIM). (I) 0112 - The condition associated with this gene has incomplete penetrance. Individuals with missense variants causing GDS or epilepsy have been reported with incomplete penetrance, but this is a rare occurrence (OMIM, PMID: 18451999). (I) 0115 - Variants in this gene are known to have variable expressivity within families with GDS (PMID: 20129935). (I) 0213 - In-frame deletion in a non-repetitive region that has high conservation. (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been reported as pathogenic, and observed in multiple individuals with early onset refractory seizures and/or GLUT1 deficiency syndrome. The variant in two of these individuals was confirmed de novo (ClinVar, PMID: 30271476, PMID: 20129935, PMID: 26193382). (SP) 1102 - Strong phenotype match for this individual. (SP) 1204 - This variant has been shown to be de novo in the proband (parental status not tested but assumed). (SP) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC2A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_6990</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006516.3:c.505_507delCTC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="612126" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_38</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7809422" SubmissionDate="2023-12-01" DateLastUpdated="2023-12-09" DateCreated="2023-12-09">
        <ClinVarSubmissionID localKey="NM_006516.4:c.505_507del|OMIM:606777" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004173433" DateUpdated="2023-12-09" DateCreated="2023-12-09" Type="SCV" Version="1" SubmitterName="Genome-Nilou Lab" OrgID="507598" OrganizationCategory="laboratory" OrgAbbreviation="Genome Nilou" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC2A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006516.4:c.505_507del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="606777" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14012453</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7926757" SubmissionDate="2024-02-02" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="4104107_NM_006516.4:c.505_507del|OMIM:606777" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004242470" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics, University of Leipzig Medical Center" OrgID="506086" OrganizationCategory="clinic" OrgAbbreviation="UKL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Criteria applied: PS4_MOD,PM4,PM6,PM2_SUP</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002313" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002384" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0007359" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0007334" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000486" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001337" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0010864" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000718" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC2A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006516.4:c.505_507del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="606777" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14199545</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4258846" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="4815222|MedGen:C3149117" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002245722" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15622525</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20129935</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31302675</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 419011). This variant is also known as 684-686delCTC. This variant, c.505_507del, results in the deletion of 1 amino acid(s) of the SLC2A1 protein (p.Leu169del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with autosomal dominant glucose transporter deficiency syndrome (PMID: 15622525, 20129935, 31302675). In at least one individual the variant was observed to be de novo.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC2A1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.43396306_43396308del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3149117" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7926757" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000718" MappingRef="HP">
        <MedGen CUI="C0001807" Name="Aggressive behavior" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7926757" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002313" MappingRef="HP">
        <MedGen CUI="C0037771" Name="Spastic paraparesis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7926757" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000486" MappingRef="HP">
        <MedGen CUI="C0038379" Name="Strabismus" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7926757" TraitType="Finding" MappingType="XRef" MappingValue="HP:0007359" MappingRef="HP">
        <MedGen CUI="C0751495" Name="Focal-onset seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7926757" TraitType="Finding" MappingType="XRef" MappingValue="HP:0010864" MappingRef="HP">
        <MedGen CUI="C0036857" Name="Intellectual disability, severe" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7809422" TraitType="Disease" MappingType="XRef" MappingValue="606777" MappingRef="OMIM">
        <MedGen CUI="C4551966" Name="Encephalopathy due to GLUT1 deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7926757" TraitType="Finding" MappingType="XRef" MappingValue="HP:0007334" MappingRef="HP">
        <MedGen CUI="C0877017" Name="Bilateral tonic-clonic seizure with focal onset" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7926757" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001337" MappingRef="HP">
        <MedGen CUI="C0040822" Name="Tremor" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4258846" TraitType="Disease" MappingType="XRef" MappingValue="C3149117" MappingRef="MedGen">
        <MedGen CUI="C3149117" Name="GLUT1 deficiency syndrome 1, autosomal recessive" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7926757" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002384" MappingRef="HP">
        <MedGen CUI="C0270834" Name="Focal impaired awareness seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5412642" TraitType="Disease" MappingType="XRef" MappingValue="612126" MappingRef="OMIM">
        <MedGen CUI="C1842534" Name="Childhood onset GLUT1 deficiency syndrome 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1101627" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7926757" TraitType="Disease" MappingType="XRef" MappingValue="606777" MappingRef="OMIM">
        <MedGen CUI="C4551966" Name="Encephalopathy due to GLUT1 deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

